Sign In
Buy AEZS
$5.72
+0 (+0%)
At Close: Nov 13, 2024
Aeterna Zentaris Announces Virtual 2020 Annual Meeting of Shareholders
01:00pm, Friday, 08'th May 2020
Shareholders will not be able to attend the AGM in-person at a physical location. To be admitted to the virtual AGM, shareholders need to visit www.virtualshareholdermeeting.com/AEZS2020 and enter th
Aeterna Zentaris Announces Virtual —…—… Annual Meeting of Shareholders
12:00am, Friday, 08'th May 202020 Healthcare Stocks Moving In Thursday's Pre-Market Session
12:00am, Thursday, 07'th May 2020AEterna Zentaris Q1 EPS $0.040 Up From $(0.300) YoY, Sales $1.100M Up From $37.000K YoY
12:13pm, Wednesday, 06'th May 2020Aeterna Zentaris Reports First Quarter 2020 Financial and Operating Results
12:05pm, Wednesday, 06'th May 2020
The Company also provided an update on its clinical program to develop macimorelin for the diagnosis of child-onset growth hormone deficiency (“CGHD”), an area of significant unmet need, and its p
One Biotech Stock For 2020
11:30pm, Sunday, 03'rd May 2020
FDA has just fast-tracked research on an exciting new mental health treatment, and one small company is making moves to secure its place as an early mover in this revolution
Gilead's remdesivir will set new standard of care for coronavirus treatment: Dr. Fauci
07:08pm, Thursday, 30'th Apr 2020
Gilead Sciences’ antiviral drug remdesivir showed “quite good news”, according to White House health advisor Dr. Anthony Fauci. Assistant Professor in Department of Health Policy and Management
The Daily Biotech Pulse: FDA Nod For UroGen, Novavax Coronavirus Vaccine To Enter Clinics, Soligenix Licenses Vaccine Adjuvant
12:09pm, Thursday, 16'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 15.) * Bio-Rad Laboratories, Inc. Class B Common Stock
Aeterna Zentaris Receives Nasdaq Notice of Non-Compliance; No Immediate Impact on Listing
08:06pm, Wednesday, 15'th Apr 2020
CHARLESTON, S.C., April 15, 2020 -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna Zentaris” or the “Company”), a specialty biopharmaceutical company.
Aeterna Zentaris to Present at the April 2020 Virtual Investor Summit
01:15pm, Wednesday, 15'th Apr 2020
A live audio webcast of the presentation will be available on the Events and Presentations page of the Investors section of the Company’s website (www.zentaris.com). The Company’s lead product, M
JTC Team and LaVoieHealthScience to Host Virtual Investor Summit on April 22 and 23, 2020
02:26pm, Thursday, 09'th Apr 2020
Press Release JTC Team ("JTC") and LaVoieHealthScience ("LHS"), today announced their partnership to host the April 2020 Virtual Investor Summit on April 22nd and 23rd from 10:00 AM - 12:00 PM ET and
JTC Team and LaVoieHealthScience to Host Virtual Investor Summit on April 22 and 23, 2020
02:10pm, Thursday, 09'th Apr 2020
The Virtual Investor Summit features public and private companies from industries such as life sciences/biotech, infrastructure and transportation.
AETERNA ZENTARIS ANNOUNCES EMA DECISION TO ACCEPT A MODIFICATION TO AN AGREED PEDIATRIC INVESTIGATION PLAN FOR MACIMORELIN
05:00pm, Tuesday, 07'th Apr 2020
– Modifications recommended for some key elements of planned safety and efficacy Study P02 – – Modifications to the outline of Study P02 requested to ensure a harmonized global.
